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Introduction 
Brugia malayi infection is endemic in 
several Asian countries: 
Malaysia, India, China 
Indonesia, Thailand, 
Vietnam, Philippines 
• -13 million people infected 
New test needed for brugian filariasis 
with following features: 
• Specific & sensitive 
• Does not need night blood sampling 
• Rapid 
• Easy to perform and interpret 
• Field applicable 
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I . B. malayi recombinant antigen (BmR1) 
u 
Indirect ELISA 
Trans Roy Soc Trop Med Hyg 2001; 
95:280-284 
u 
Further purification and concentration 
u 
Development of dipstick test 
Dipstick test (Brugia Rapid) = 
• Detects specific lgG4 antibodies in 
infected individuals 
• tmmunochromatography 
• 1 0-15 minutes 
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Sensitivity 
Sensitivib! studies 
mf+ Dipstick Dipstick Sensi-
+ve -ve tivity 
::::::· 
India 51 50 1 98.0% 
lndon 108 101 7 92.6% 
·•· ... : 
Nether- 207 191 16 92.3% 
lands 
M'sia 69 69 0 100% 
:·. 
•.•)> 
·::;:: 
Swiss 6 6 0 100°/o 
Total 441 417 24 94.6% 
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Correlation of mf count and lgG4titer 
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Specificity studies I 
Soil-transmitted helminths 
No. Dipstick 
samples 
-ve 
M'sia 51 50 
lndon 19 19 
Swiss 6 6 
Total 76 75 
Specificity studies II 
Non-filarial helminths 
No. Dipstick 
samples -ve 
M'sia 50 49 
lndon 10 10 
Swiss 49 49 
Total 109 108 
Dipstick Specifi-
+ve city 
1 98% 
0 1QQOA, 
0 100% 
1 98.7% 
Dipstick Speci-
+ve ficity 
1 98.0% 
0 100% 
0 100% 
1 99.1% 
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Specificity studies Ill 
Protozoa 
No. Dipstick 
samples -ve 
M'sia 225 223 
lndon 13 13 
Swiss 19 19 
Total 257 255 
Dipstick Specifi-
+ve city 
2 99.1% 
0 100°/o 
0 100% 
2 99.2% 
* 12 samples from bacterial & viral infections were all 
dipstick negative 
Specificity studies IV 
Healthy people 
No. 
samples 
M'sia 130 
Nether- 220 
lands 
Swiss 10 
USA 36 
India 20 
Total 416 
Dipstick Dipstick Specifi-
-ve +ve city 
128 2 98.5% 
220 0 100o/o 
10 0 100% 
36 0 100% 
20 0 100% 
414 2 99.5% 
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Microfilaria Microfilaria Total 
positive negative 
Dipstick 417 6 423 
positive 
Dipstick 24 864 888 
negative 
441 870 1311 
Sensitivity 417/441 = 94.6% ~~~~; 
Specificity 864/870 = 99.3°A. 
PPV 417/423 = 98.6% 
... 
NPV 864/888 = 97.3o/o 
Other evaluation results 
8 
'Endemic normals' 
1. Malaysia (low endemicity) 
28 out of 1134 were pos (-2.5%) 
2. India (higher endemicity) 
3 out of 30 were positive (10%) 
=:) detects cryptic infections 
Field trial in Sarawak, Malaysia 
No. Thick blood Dipstick 
samples smear positive positive 
Miri 238 2 8 
·-: ..... 
·=~=· 
Kuching 206 5 31 
444 7* 39 
{1.58o/o) (8.78%) 
*All dipstick positive 
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Treatment studies 
(i) Treatment of microfilaraemics 
'A: 
No. Period post- Dipstick 
samples treatment negative 
M'sia 15 6 mo- 2 yrs 15 (100%) :r,i~ 
Nether- 55 l-3yrs 19 (35%) 
lands 
India 21 lyr 9 (30%) 
Malaysia Flgure2 
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(Eiisd) 
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~(manlh~ 
Period post-treatment 
::~~~ 
1.0 
Comments 
·:~~ 
100 Negative X 
9 50 50 Negative X 
10 800 400 Negative X 
~~~ 
Symptomatic i!,microfilaraemics 
No. Dipstick Dipstick 
-ve +ve :;?::~: 
Swiss 6 0 6(100o/o) 
adenolymph. 
In don. 17 10(59%) 7 (41%) 
:~~;: 
-adenolymph. 
-lymphoedema 
Nether- 1 1 (100%) 0 ~1~· 
lands 
Total 24 11 (46%) 13 (54%) 
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Chronic infections 
No. Dipstick Dipstick 
sample -ve +ve 
India 30 19 (63%) 11 (37%) 
In don 43 25 (58%) 18 (42%) 
Nether- 116 45 (39%) 71 (61%) 
lands 
Swiss 7 6 (86%) 1 (14%) 
Total 196 96 (49%) 101 (51%) 
• • 
W. bancrofti mf+ 
No. Dipstick Dipstick Sensiti 
samples +ve -ve -vity 
USA 56 30 26 53.4% 
lndon 20 14 6 70.0% 
India 22 12 10 54.5o/o 
Swiss 10 9 1 90% 
Total 108 65 43 60.2% 
_Not sensitive for detection of bancroftian filariasis 
_ Cannot be used to differentiate the two filaria species 
12 
t 
Non-lymphatic filaria 
No. Dipstick Dipstick Specifi 
samples -ve +ve -city 
USA 133 124 9 93.0°/0 
M'sia 8 8 0 100% 
Swiss 12 12 0 1QQOJ(, 
Total 153 144 9* 94.1% 
* 8 Loa-loa, 1 Oncho 
Conclusion 
Good specificity & sensitivity, 
thus is potentially very useful for 
use in diagnosis and elimination ,~~ 
program for brugian filariasis 
13 
Dipstick with 
blood filter 
Brugia Rapid 
MAb anti-human 
IgG4-gold 
:~. 
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DISCARD 
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Possible areas for future improvements 
1. Increase simplicity of procedure :;~~ 
for greater field applicability. 
2. Use of cocktail of recombinant antigens : ~$~;, 
i. increase sensitivity of current test 
ii. sensitive detection of both brugian and 
bancroftian filarial infections 
Research funds received from: 
• Malaysian Ministry of Science & 
Technology 
• Universiti Sains Malaysia 
• UNDPJWorld BankJVVHO(TDR) 
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Abstract 
A total of 753 serum samples from six institutions were used to evaluate an 
immunochromatographic rapid dipstick test (Brugia Rapid) for diagnosis of Brugia 
malayi infection. The samples comprised of sera from 207 microfilaria positive 
individuals and 546 individuals from filaria non-endemic areas. The latter consisted of 70 
individuals with soil-transmitted helminthic infections, 68 individuals with other 
helminthic infections, 238 individuals with protozoan infections, 12 individuals with 
bacterial and viral infections and 158 healthy individuals. The dipstick is lined with goat 
anti-mouse antibody (control line) and a B. malayi recombinant antigen (test line). First, 
the dipstick is dipped into a well containing diluted patient sera, thus allowing specific 
anti-filarial antibody in the serum to react with the recombinant antigen. Then the 
dipstick is placed into an adjacent well containing reconstituted anti-human IgG4-gold. 
After 10 minutes, development of two red-purplish lines denotes a positive result and one 
line indicates a negative reaction. The overall results of the evaluation showed 91 % 
sensitivity, 99% specificity, 97% positive predictive value and 99% negative predictive 
value. Brugia Rapid is thus a promising diagnostic tool for detection of B. malayi 
infection, and would be especially useful for the brugian filariasis elimination 
programme. 
Introduction 
The World Health Organization has initiated a global programme for the elimination of 
lymphatic filariasis, namel~ W~chereria bancrofti, Brugia malayi and Brugia timori. 
(WHO, 1997.) By 2020,. this ~s~ase _which infects approximately 120 million people, 
could be eliminated. This optu:msm IS_ based. on several reasons, one of them is the 
availability of a rapid fiel~-applicable d1a~~st1c tool for W b~ncrofti, the major species 
of lymphatic filarial paras~te .. However a s~lar tool for ~e~ectlon .of bmgian filariasis is 
still being sought, since ~t infects a~prox1ma~~ly .13 mtlhon Ast~s, mainly in India, 
Indonesia, South China, Vtetnam, Thatland, Phihppmes and Ma1ays1a. 
Previously we have reported ~n a sensitive and specific recombinant antigen-
based Ig4-ELISA for detection of B. malayi infection (RAHlv1AH et al., 2001). This 
recombinant, antigen and immunoassay has now been further developed into a rapid 
immunochromatographic dipstick test fonnat (Brugia Rapid) and an evaluation study 
performed on this test is hereby presented 
Materials and methods 
Serum samples 
A total of 753 serum samples were obtained from six institutions of three countries 
namely 295 samples from Universiti Sains Malaysia (USM), 158 samples from 
University of Indonesia (FKUI), 50 samples from T.D. Medical College (TDMC, India), 
100 samples from Universiti Malaya (UM, Malaysia), 100 samples from Institute of 
Medical Research (IMR, Malaysia) and 50 samples from Universiti Kebangsaan 
Malaysia (UKM). All sera used were from the sera bank of each institution, these 
samples were previously obtained from consenting individuals in accordance with the 
requirements of each institution. For the USM samples, the following sera were kindly 
contributed by various researchers : 4 microfilaria positive sera and 9 soil-transmitted 
helminthiases sera from Dr. Chotechuang Panasoponkul (Thailand); Anasakis sera from 
Professor Akihik:o Yano (Japan); and Schistosoma mansoni sera from Professor Hassan 
Mohamed El-Hady (Egypt). Table 1a shows the kinds of samples obtained from each 
institution and table 1 b shows the details of the samples from the other infections. 
Recombinant antigen (Bm.Rl) 
The novel B. malayi recombinant antigen was prepared as previously decribed 
(RAHMAH et a/., 2001). Briefly, 1: 100 dilution of an overnight culture of the 
recombinant bacteria in Luria Bertani broth was subcultured into Terrific broth and 
incubated at 3'fC in a shaker-incubator until OD60o 0.5 was attained. The culture was 
then induced with lmM IPTG for 3 h at 30°C. The bacterial pellet was reconstituted with 
lysis buffer containing a cocktail of protease inhibitors. The suspension was then 
sonicated, centrifuged and the supernatant passed through Ni-NTA affmity column. 
Rapid dipstick test (Brugia Rapid) 
This test was developed using the above recombinant antigen and 
immunochromatography dipstick technology. Membrane card (Millipore, USA) was 
manually lined with goat anti-mouse antibody (Arista Biologicals, USA) as the top 
control line and the recombinant antigen as the second test ~e; these two lines are about 
5 mm apart. The lined card was dried and treated with a blocking solution. An absorbent 
pad (3 em) was pasted on the adhesive area on top of the card, then the pad was covered 
with blue vinyl tape. A serum filter (-- 5 mm) was pasted onto the adhesive area at the 
bottom of the card. The assembled card was then cut into 4 mm strips. Monoclonal anti-
human IgG4 antibody (Z~ed, USA) was sent for gold-c.onjugation (~sta Biologicals, 
USA); a gold solution ~~~e was prepared anq the~ ci?e~ ~nto plastic wells. In a dry 
room (20% relative hwm?tty!, the tests we~e placed m mdivt_dual pouches; ~ach pouch 
contained a dessicant, a dipstick and one parred wells. The parred wells conststed of one 
empty well (A) attached to another well (B) containing the dried gold conjugate. The 
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pouches, dessicants, strip cutter, heat sealer and dry room facilities were kindly provided 
by a local diagnostic kit manufacturer (Malaysian BioDiagnostic Research ). 
The test was performed as follows: Upon opening of the pouch, the paired wells 
are placed snugly into an empty microwell (96-well plate which functions like a rack). 25 
f.ll of phosphate buffered saline (PBS, pH 7.2) is placed in well Band 15 f.ll of the buffer 
in well A Next, 15 J.1l of serum is added to well A and briefly mixed with the buffer. The 
dipstick is then placed in well A and the sample is allowed to flow up the nitrocellulose 
strip by capillary action. In the meantime, the reconstituted reagent in well B is mixed 
with a pipettor. When the sample front almost reaches the blue vinyl tape, the dipstick is 
lifted &nd using a pair of scissors, the serum filter is cut off (and thrown into a container 
with disinfectant). The dipstick is then placed in well Band the timer set for 10 minutes. 
The top line, containing goat anti-mouse antibody, serves as a control to ensure the 
stability of gold-conjugation of the monoclonal anti-human IgG4 antibody, thus it must 
appear (as red-purplish line) after the completion of either a positive or negative test. 
Failure of appearance of the control line indicates a defective test. The bottom line is the 
test line, containing B. malayi recombinant antigen, which only develops when the serum 
sample contains anti-filarial IgG4 antibodies specific to the antigen. Thus the final result 
in a positive test is the appearance of two red-purplish lines. When a negative serum is 
· used, binding with the recombinant antigen does not occur, thus only the top control line 
will develop/appear as one red-purplish line. 
For USM and Indian samples, the tests were performed at USM These sera were 
randomized by a technician from another department and the sample identities decoded 
after the dipstick results were interpreted. For the other samples, the tests were 
performed by the personnel of the respective institutions. 
Result$ 
Table 2 shows a summary of the results of the evaluation while table 3 shows the 
statistical analysis of the results. The latter demonstrated 97% sensitivity, 99% 
specificity, 97% positive predictive value and 99% negative predictive value. The 1 % 
(6/546) false positive results were obtained from 2 serum samples of blood donors, 2 
serum satn.ples from E. histolytica infections, 1 serum sample from hookworm infection 
and 1 serum sample from Toxocara infection. The false positives are not restricted to any 
particular group of infections, and thus may be due to factors other than the respective 
infections. The 3.4% (7/207) false negative results were obtained from seven 
microfilaraemic samples from Indonesia. No false negatives were obtained from 
micrifilaraemic samples from Malaysia, India and Thailand. 
In general this test which takes --12 minutes to complete, is easy to perform and to 
interpret. Since it is performed on a 96-well microtitre plate, at least four to five tests can 
be simultaneously performed ~y one person, thus making it more convenient and time-
saving, especially when screemng large number of samples. 
Discussion . 
A specjfic sensitive, rapid, field-appbcable test for detection of B. malayi infection is 
urgently n~eded fo~ acc~~te ~apping of brugian filariasis ende~c are~s in the ongoing 
lymphatic filariasis eli1tllJUltiOn progr~e. It would ~e desrrab~e tf a monoclonal 
antibody is available that can be developed mto a good antigen detection rapid test for B. 
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malayi infection, similar to that of the ~ bancrofti ICT card test. However, until such a 
test is developed, the best alternative would be the use of recombinant antigen(s) that can 
detect specific anti-filarial IgG4 antibodies. This antibody subclass has been shown to be 
elevated in active lymphatic filaria infection {OTTESEN et al., 1985; KWAN-LIM: et al., 
1990; KURNIAWAN et al., 1993; RAHMAH et al., 1998a; HAARBRINK et al., 1999) 
and to significantly decline after chemotherapy (WAMAE et al., 1992; Me CAR1HY et 
a/., 1995; KURNIAWAN eta/., 1995). . 
In this study, a newly developed rapid dipstick test (Brugia Rapid) for detection 
of B. malayi infection was evaluated for sensitivity and specificity using 753 sera samples 
from six institutions. Statistical analysis of this first evaluation study showed 
encouraging results i.e. 99% specificity, 97% sensitivity, 99% negative predictive value 
and 97% positive predictive value. . 
Among the 207 sera from microfilaraemic individuals; seven samples, all from 
Indonesia, were found be negative. Brugia-Elisa using the same recombinant antigen 
was performed on these seven samples and the results remained negative. However when 
IgG4-Elisa using soluble B. malayi adult antigen was performed, it showed positive 
results in three (out of seven) of these samples. The C?ther four sera could thus be from 
individuals who are low IgG4 responders. In a previous study (MARLEY et al., 1995). 
using B. pahangi soluble antigen, 10% of microfilaraemic individuals were found to have 
low levels of antifilarial IgG4 antibody. A cocktail of two or more highly specific and 
sensitive recombinant antigens, if available, may further increase the sensitivity and thus 
the robustness of the dipstick test. 
With regards to the sampling areas, five of these false-negative samples were 
from nocturnal periodic areas of brugian filariasis, while two were from a subp~riodic 
area. In comparison Malaysian samples were from subperiodic areas, while Indian 
samples were all from nocturnal periodic infections. In order to determine whether strain 
differences may affect sensitivity of the test, much larger number of samples from each 
of the periodic and subperiodic areas need to be tested. · 
Similar to the previous results using the recombinant antigen-based IgG4 ELISA 
(RAHMAH et al., 2001), initial follow-up studies on treated individuals showed that 
Brugia Rapid remained positive for about 6 months to two years post-treatment. More 
data is being gathered on this aspect; however the possibility of insufficiently treated 
individvals or of reinfection complicates interpretation of such follow-up studies. 
Sensitivity of the dipstick to sera of Wuchereria bancrofti microfilaraemic 
individuals was found to be 54.5% for samples from India (12/22; samples were kind 
contribution from Professor P. Kaliraj) and 70% for Indonesian samples (14/20). The 
reason for the cross-reactivity is not yet understood However this should not be a 
problem since the treatment for both species of lymphatic filaria is similar. In fact it may 
be advantageous if this test could be further developed to detect most cases of bancroftian 
filariasis. . 
Further evaluation studies using bigger sample sizes will soon be conducted. 
These would also comprise samples from non-lymphatic filarial infections; although in 
general they are not co-ende~c ~~ lymphatic filariasis and thus would not pose a 
problem. The evaluati~n studtes Will mclude _a WHO~spons~red three centre laborat~ry 
evaluation, field trials m a mod~rate B. ~a/ayz endenuc area m Sarawak: (East Malaysta) 
and in bmgian filariasis endemtc areas tn Indonesia. The field trials will utilize blood 
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tests, whereby a blood filter replaces the serum filter on the dipstick and the sample used 
will be 50 ul of blood with anti-coagulant. 
PCR-ELISA assays have been reported for the sensitive detection of B. malayi 
infection (LIZOTTE et al., 1994; RAHMAH et al., 1998 b, FISCHER et al., 2000). 
Recently, DNA dipstick test for B. malayi infection has been developed (£<LUBER et al., 
2001) which will allow rapid detection of PCR product. The combined usage of blood 
sample spots on filter paper and DNA dipsticks would make PCR detection of infected 
individuals more convenient. But, this will still involve sending samples to central 
laboratories and on-site test interpretation cannot be performed, thus making the PCR-
based test not truly field-applicabl~. Other than the relative higher cost and the possible 
mix--up of samples that may occur in the multi-step processing of large number of blood 
spots; PCR-based DNA dipstick may not detect cryptic infections. Nevertheless, 
comparison between Brugia Rapid and DNA dipstick in a field evaluation would be 
another important study that should be performed. These two tests may in fact, be useful 
as complementary diagnostic tools in the brugian filariasis elimination programme. The 
former IgG4 antibody ... detection will probably be positive for a longer time post-
treatment, while the latter DNA detection test will likely to be less sensitive in detecting 
amicrofilaraemic infections. These disadvantages of the two tests could be minimized by 
utilizing a multitest approach in detection of B. malayi infection 
In conclusion, this study qemonstrated the high specificity and sensitivity of the 
Brugia Rapid dipstick test Therefore, this is a promising tool to be used as a laboratory 
diagnostic test and to assist in the brugian filariasis elimination programme. 
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J&gend to tables 
1. Table la: Categories of serum samples from various institutions used in the 
. evaluation of Brugia Rapid 
2. Table 1 b: Details of serum samples from other infections used in the 
evaluation of Brugia Rapid 
3. table 2: Results of evaluation of Brugia Rapid using various categories of 
serum samples from six institutions 
4. Table 3 : Specificity and sensitivity of Brugia Rapid for the diagnosis of 
brugian filariasis, as assessed by serum samples from six 
institutions 
Table 1 a 
Serum USM FKUI TDMC UM IMR UKM Total 
samples 
Microfilaria 39 108 ·30 10 20 0 207 
positive 
Soil-
transmitted 39 19 0 0 0 12 70 
helminthiases 
Other 
helminth 32 10 0 26 0 0 ·68 
infections 
Protozoan 72 13 0 47 80 26 238 
Infections 
Other 12 0 0 0 0 0 12 
infections 
Healthy 101 8 20 17 0 12 158 
individuals 
Total 295 158 50 100 100 50 753 
Note: Except for the microfilaria positive serum samples, all other samples were from 
indiviquals residing in non-filaria endemic areas. 
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Table lb 
Cateeory Species No. Total 
Soil-transmitted Ascaris lumbricoides 16 
helminthiases Trichuris trichuria 21 
Hookworm 14 70 
Strongyloides stercora/is 1 
Mixed infections 18 
Other helminthic Toxocara 31 
infections Gnathosthoma spinegerum 1 
Taenia solium ( cystercercosis) 11 
Dirofilaria immitis 5 
Anasakis 8 
Schistosoma mansoni 9 68 
Onchocerca volvulus 3 
Protozoan Toxoplasma gondii 118 
infections Plasmodium vivax & P. falciparum 41 
Entamoeba histo/ytica 72 
Iodamoeba butschlii 2 
Gardia Iamblia 2 238 
Cryptosporidium parvum 2 
Leishmania 1 
Other infections Dengue l 
Scrub typhus 1 
Hepatitis 4 12 
Salmonella typhi 5 
Cam~obacter.i~iuni 1 
Total 388 
8 
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Table2 
Serum sample No. Brugia Rapid positive(%) 
Microfilaria 200 (96.6%) 
pos. individuals 207 
Soil-transmitted 1 (1.4%) 
helminthiases 70 
Other 1 (1.5%) 
helminthic 68 
infections 
Protozoal 2 (0.8%) 
infections 238 
Other infections 0 (0%) 
12 
Healthy 2 (1.3%) 
individuals 158 
Total 
753 
Table3 
True 
200 
7 
207 
Sensitivity : 200/207 = 96.6% - 97% 
Specificity : 540/546 = 98.9% - 99 % 
PPV 200/206 = 97.1 % -97% 
NPV 540/547 = 98.7% - 99% 
9 
Brugla Rapid negative (%) 
7 (3.4%) 
69 (98.6%) 
67 (98.5%) 
236 (99.2%) 
12 (100%) 
156 (98.7%) 
Total 
206 
547 
753 
